Excision BioTherapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States11-50 Employees
Excision BioTherapeutics is a privately held biotechnology company based in Watertown, Massachusetts, focused on developing gene editing therapeutics to address life-threatening diseases caused by viral infections. The company aims to translate these gene editing approaches into safe and effective medicines that can improve the lives of infected individuals worldwide. It operates within the biotechnology research sector, prioritizing clinical programs that address viral infections. Its programs target hepatitis B and herpes simplex virus infections, reflecting a focus on treating viral diseases through gene editing. As a clinical-stage company, it has shared updates on HBV and HSV programs at industry meetings, including a September 2025 presentation that highlighted positive preclinical data for the HBV EBT-107 program.